Here's the honest picture: Strong: Consistent positive results in animal studies Multiple mechanisms that make biological sense Good safety profile in research settings Decades of study without major red flags Weak: Limited human clinical trials Not FDA approved for any indication Long-term effects unknown Quality control issues with commercial products The peptide is stuck in an odd place
Targeting mitochondrial quality control: New therapeutic strategies for major diseases
Murphy E, Rigoutsos I, Shibuya T, Shenk TE
While our previous work ( Furthermore, to bridge the gap between basic research and clinical application, we uniquely highlight the latest breakthroughs in natural/dietary compounds and advanced drug delivery systems (e.g., nanocarriers and hydrogels) designed to overcome the blood-retinal barrier
According to published research, gynecomastia is primarily caused by an increased circulating estrogen to androgen ratio ( Depending on the progression of the condition, gynecomastia may be reversed in the early stages